InsidersTradesSigma
Discover the full record of transactions filed by O'Neill Gilmore Neil, Chief Executive Officer. Insider active across 1 companies, notably Editas Medicine, Inc.. In total, 1 reports have been published. The latest transaction was disclosed on 2 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Neil O'Neill is the Chief Executive Officer of Editas Medicine, Inc., a pioneering company in the field of genomic editing. Under his leadership, the company focuses on developing innovative therapies based on CRISPR technology. Neil brings extensive experience in biotechnology and business management, guiding Editas towards significant advancements in the treatment of genetic diseases.